Abstract: Disclosed herein are embodiments of a duct support assembly. The duct support assembly can include a frame structure and a duct support. The duct support can be configured to be installed in a floor assembly between a first beam portion of a first wall frame and a second beam portion of a second wall frame and to provide a duct exit from the frame structure. The duct support can be configured to transfer a tension and/or compression load. Also disclosed herein are embodiments of a method of using a duct support to provide a duct exit from a frame structure. The method can include positioning the duct support in a floor assembly between a first beam portion of a first wall frame and a second beam portion of a second wall frame.

Abstract: Drug-delivery systems configured to generate indications regarding a user's level of skill, familiarity, or experience with operating such systems are described. The systems may comprise a syringe assembly, one or more skin contact sensors, and one or more syringe assembly sensors configured to detect initiation and/or completion of a dispensing event. The system may further comprise one or more processing circuits configured to measure a time duration between when the skin contact sensor(s) detect contact with skin tissue and when the syringe assembly initiates a dispensing event, compare the measured duration against a threshold time duration, and generate a user indication signal if the measured duration exceeds the threshold time duration.

Abstract: Various implementations include a fused filament fabrication print head system that includes a nozzle, a heating block, and a cooling element. The nozzle defines a nozzle opening and a filament flow path and is configured to deposit a filament through the nozzle opening. The heating block is coupled to the nozzle such that the filament flow path extends through the heating block. The heating block includes a heating element. The cooling element is spaced apart from the heating block along the filament flow path and is configured to provide localized cooling to a portion of the filament at a location along the filament flow path prior to the heating block. The localized cooling provided by the cooling element preserves the stiffness of the filament and ensures sufficient back pressure to push the filament through the heating block and nozzle opening.

Abstract: Methods and systems are provided for evaluating injection sites on a body of a patient. The methods/systems may instruct a patient to place one or more capacitance sensors in contact with a potential injection site on the body of the patient. The methods/systems may also comprise using a processing circuit to receive data indicative of a capacitance of body tissue at the potential injection site, as measured by the one or more capacitance sensors. The methods/systems may also comprise generating, using the processing circuit, an indication of a level of pain that would be expected to be experienced by the patient from a potential injection at the potential injection site based on the received capacitance.

Abstract: Disclosed herein are embodiments of a duct support assembly. The duct support assembly can include a frame structure and a duct support. The duct support can be configured to be installed in a floor assembly between a first beam portion of a first wall frame and a second beam portion of a second wall frame and to provide a duct exit from the frame structure. The duct support can be configured to transfer a tension and/or compression load. Also disclosed herein are embodiments of a method of using a duct support to provide a duct exit from a frame structure. The method can include positioning the duct support in a floor assembly between a first beam portion of a first wall frame and a second beam portion of a second wall frame.

Abstract: An injection device may include a housing and a baseplate coupled to the housing. The baseplate may include a flange portion and an axial portion that extends from the flange portion in a longitudinal direction of the housing. The baseplate may be an opaque, polymer material that is more thermally conductive than a material of the housing. The injection device may additionally include a syringe at least partially disposed within the housing. The syringe may include a needle. The injection device may include a deployment mechanism configured to move the syringe relative to the housing from a retracted position to a deployed position in which the needle projects beyond the baseplate. At least a portion of the syringe may be visible when the syringe is in the retracted position.

Abstract: Plant-based nutritional compositions comprise fava bean protein isolate and pea protein. The fava bean protein isolate comprises greater than about 10 wt % of the total protein in the composition, and the pea protein comprises less than about 50 wt % of the total protein in the composition. In certain embodiments, the nutritional compositions are high in protein, high in fiber, and low in calories. The compositions may be dairy-free and/or soy-free.

Abstract: The present disclosure relates to drug delivery devices, and in particular, to drug delivery devices configured to reconstitute a lyophilized drug powder into liquid form prior to delivery into a patients body. In some embodiments, such devices include a flexible drug reservoir having a proximal reservoir component storing a liquid diluent and a distal reservoir component storing a lyophilized drug powder, wherein the two compartments are separated by a frangible seal. A compression member may be positioned above the reservoir and held up by a releasable mechanism. When released, the compression member may be driven downwards to compress the proximal compartment so as to break the frangible seal and allow the diluent to mix with the drug powder and form a liquid drug mixture, and then to eject the liquid drug mixture from the reservoir.

Abstract: Disclosed herein are embodiments of a duct support assembly. The duct support assembly can include a frame structure and a duct support. The duct support can be configured to be installed in a floor assembly between a first beam portion of a first wall frame and a second beam portion of a second wall frame and to provide a duct exit from the frame structure. The duct support can be configured to transfer a tension and/or compression load. Also disclosed herein are embodiments of a method of using a duct support to provide a duct exit from a frame structure. The method can include positioning the duct support in a floor assembly between a first beam portion of a first wall frame and a second beam portion of a second wall frame.

Abstract: A formulation consisting of Thymol Iodide, in a Lanolin, Petrolatum, Zinc Oxide, Olive Oil base is applied to a topical skin lesion. Observed also and after discussions with patients, caregivers and patient relatives, it was discovered that a certain formulation consisting of an active pharmaceutical ingredient together with a specific base formulation promoted curing and accelerated healing of a variety of conditions. This formulation was examined for its superior effectiveness leading to the discovery found within this patent application. Such a formulation will have a drastic reduction of healthcare costs because the topical application of this formulation will effect improvement, cure and accelerated healing resulting in no need for costly operations, hospitalizations, or long-term treatment.

Abstract: Multi-mode transceiver and a circuit for operating the multi-mode transceiver. A multi-mode transceiver includes a first circuit that is configurable to operate as one of a transmitter and a receiver in a first mode, and a second circuit that is configurable to operate as one of the transmitter and the receiver in a second mode. The multi-mode transceiver includes a first element coupled to the first circuit. The multi-mode transceiver includes a second element coupled to the first element and one or more ports. The multi-mode transceiver also includes a first switch, coupled to the second element and to the second circuit, that is configurable to operate the transceiver in at least one of the first mode and the second mode in conjunction with the first element and the second element.

Abstract: Disclosed are flavored nutritional beverages comprising (A) fat; (B) milk protein representing from about 10% to 100% by weight of total protein; (C) carbohydrate comprising from about 75% to 100% by weight of at least one of (i) from about 0.1% to about 10% sucrose, trehalose, or combination thereof, by weight of the beverage, and (iii) from about 0.1% to about 20% maltodextrin by weight of the nutritional liquid, the maltodextrin having a DE value of from about 1 to about 10, and (iii) combinations of (i) and (ii); (D) an iron-containing material, and (E) a flavorant. The flavored nutritional beverages, unlike many iron-fortified milk-based beverages available today, do not readily develop beige or gray hues during formulation, processing and storage, and are thus more easily formulated with little or no color distortion and with improved or more accurately matched flavor-color combinations.

Abstract: VCO frequency is continuously variable through a wide frequency range in proportion to a first control voltage VC produced by a PLL containing the VCO. A second control voltage NVC is produced as a monotonically decreasing function of VC. A first current I0 is produced in proportion to VC and a second current I1 is produced in proportion to NVC. I1 is subtracted from I0, producing a control current IC=I0-I1 which is applied to the VCO.